Professional
Added to YB: 2024-10-16
Pitch date: 2024-10-15
MEDP [bullish]
Medpace Holdings, Inc.
+40.48%
current return
Author Info
LVS Advisory is a boutique investment firm focused on providing active investment management services for individuals, families, and institutions. Sign up for the newsletter.
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
$12.8B
Pitch Price
$353.08
Price Target
N/A
Dividend
N/A
EV/EBITDA
20.52
P/E
29.53
EV/Sales
4.92
Sector
Life Sciences Tools and Services
Category
growth
LVS Growth Fund Portfolio Holding: Medpace Holdings, Inc.
MEDP: CRO leader in small biotech niche. 20%+ 10yr rev growth, 50%+ ROIC. Organic growth, vertically integrated, low-cost advantage. 5% market share in $28B segment growing 8%. Stock down 20% on biotech R&D slowdown. 14% 2024 growth. Trading at low 20s P/E. Long-term growth intact.
Read full article (4 min)